• SENSEX 76,299.74
    -317.70 (--0.41%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • Mazagon Dock
    2,720.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • Hind.Aeronautics
    4,309.00 5,675.00(%)
  • TCS
    3,396.10 3,457.35(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,783.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    655.20 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Emcure Pharma
    1,040.30 911.75(%)
  • Jio Financial
    231.75 394.70(%)
  • Reliance Power
    44.44 54.25(%)
  • IndusInd Bank
    714.65 1,576.00(%)
  • ICICI Bank
    1,306.55 1,048.35(%)
  • Zomato Ltd
    214.00 304.50(%)
  • Zydus Lifesci.
    949.85 1,323.90(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alembic Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 40294.0
  • ISIN : INE901L01018
885.00 -12 (-1.32%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    877.75

  • Today’s High

    906.30

  • Open

    904.80

  • Perv Close

    896.85

  • 52W Low

    725.20

  • 52W High

    1,303.90

Key Indicators

  • P/E(TTM)

    28.11

  • Mar.Cap (₹Cr.)

    17,395.84

  • Div & Yield %

    1.24

  • Book Value(₹)

    255.98

  • Debt-Equity Ratio

    -1.32

  • AGM Date

    02-Apr-2025

  • EPS

    31.49

  • P/E Ratio

    28.11

Financials Ratios

  • Debt-Equity Ratio

    0.13

  • Mar.Cap (₹Cr.)

    17,395.84

  • RONW (%)

    13.40

  • ROCE (%)

    12.93

Score Board

  • Equity (₹ in Cr.)

    39.31

  • BV (₹)

    256.00

  • Sales( ₹ in Cr.)

    5,874.06

  • NP (in Cr.)

    665.49

  • NP Var(%)

    92.0

  • Div%

    550.0

  • CPS (₹)

    47.70

  • EPS (₹)

    33.90

  • Traded Value (₹ in Lakhs)

    17,399.77

  • 52 Week High

    1,303.90

  • 52 Week Low

    725.20

  • Price BSE

    885.0

  • Price NSE

    885.00

  • Market Capital( in Cr.)

    17,399.77

  • P/C Ratio

    18.60

  • P/E Ratio

    26.10

  • Price Vs.BV

    33.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 5,874.06 5,149.00 5,035.41 5,066.89 4,132.55 3,660.27
Excise Duty 5,757.55 5,003.13 4,987.49 4,950.00 4,019.53 3,533.84
Net Sales 5,874.06 5,149.00 5,035.41 5,066.89 4,132.55 3,660.27
Other Income 31.32 3.54 51.14 83.90 134.75 6.42
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 5,905.38 5,152.54 5,086.55 5,150.79 4,267.30 3,666.69
EXPENDITURE :
Raw Materials 5,757.55 5,003.13 4,987.49 4,950.00 4,019.53 3,533.84
Power & Fuel Cost 5,757.55 5,003.13 4,987.49 4,950.00 4,019.53 3,533.84
Employee Cost 1,335.91 1,094.82 1,062.30 976.13 806.37 684.45
Other Manufacturing Expenses 46.19 48.31 28.82 26.07 27.52 11.97
Selling & Administrative Expenses 1,191.90 1,173.00 1,088.67 848.55 661.00 762.72
Miscellaneous Expenses 46.19 48.31 28.82 26.07 27.52 11.97
Less : Pre-operative Expenses Capitalised :
Total Expenditure 5,201.15 4,806.61 4,428.54 3,813.05 3,090.51 2,902.06
Operating Profit 501.19 508.40 444.60 462.75 388.87 322.39
Interest 54.47 49.00 17.02 12.98 25.19 14.87
Gross Profit 704.23 345.93 658.01 1,337.74 1,166.79 764.63
Depreciation 271.14 272.95 284.92 182.55 135.67 105.59
Profit Before Tax 704.23 345.93 658.01 1,337.74 1,166.79 764.63
Tax 41.50 0.00 115.70 241.20 198.48 157.52
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 666.48 346.73 543.55 1,096.54 969.40 611.21
Extraordinary Items 704.23 345.93 658.01 1,337.74 1,166.79 764.63
Adjusted Net Profit 666.48 346.73 543.55 1,096.54 969.40 611.21
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 216.22 157.25 196.56 275.19 188.52 103.68
P & L Balance carried down 666.48 346.73 543.55 1,096.54 969.40 611.21
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 550.00 400.00 500.00 700.00 500.00 275.00
Dividend Per Share(Rs) 11.00 8.00 10.00 14.00 10.00 5.50
Earnings Per Share-Unit Curr 33.91 17.64 27.65 56.60 51.42 32.42
Book Value 216.22 157.25 196.56 275.19 188.52 103.68
Book Value(Adj)-Unit Curr 216.22 157.25 196.56 275.19 188.52 103.68

Shareholding Pattern

  • Promoter Group

    69.61%

  • Public Share Holding

    30.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,006,980 1,006,980.00 1,006,980 1,006,980
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,006,980 0.51 1,006,980 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 126,134,234 64.17 126,134,234 7
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,535,239 4.85 9,535,239 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 151,800 0.08 151,800 8
Others 0 0.00 0 0
Sub Total 135,821,273 69.10 135,821,273 25
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 53,650 0.03 38,550 7
Foreign Bank 3,250 0.00 3,250 1
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,194,040 4.17 8,194,040 162
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,172,726 6.70 13,172,726 10
Mutual Funds / UTI 17,619,205 8.96 17,619,205 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 715,773 0.36 715,773 12
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 39,758,644 20.23 39,743,544 213
2] Non Institution
Bodies Corporate 328,882 0.17 320,682 409
Clearing Members 547 0.00 547 8
Directors of their Relatives 2,409,578 1.23 2,409,578 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 880,202 0.45 879,827 2,021
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 445,893 0.23 445,053 1,650
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,239,220 0.63 1,239,220 6
Individuals holding nominal share capital up to Rs. 1 lakh 13,033,770 6.63 12,014,294 89,560
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 23,387 0.01 23,387 7
Others 1,539,960 0.78 1,539,960 1
Sub Total 19,976,227 10.16 18,947,336 93,705
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 196,563,124 100.00 195,519,133 93,944

Company Background

Alembic Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alembic Pharmaceuticals Ltd
  • BSE Code : 40294.0
  • ISIN : INE901L01018

  • Incorporation Year

    2010

  • Registered Office

    Alembic Road
    , Vadodara,
    Gujarat-390003

  • Telephone

    91-0265-2280550

  • FAX

    91-0265-2282506

  • Chairman

    Chirayu R Amin

  • Managing Director

    Pranav Amin

  • Company Secretary

    Manisha Saraf

  • Auditor

    K C Mehta & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Link Intime India Pvt Ltd
    B-102&103 Shangrila,
    Complex First Floor,Akota
    Mumbai - Vadodara - 390 020

Alembic Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alembic Pharma 885.20 5,905.38 5,874.06 27.64 14.13
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92